Terms: = Head and neck cancer AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671 AND Staging
202 results:
1. Dosimetry during iodine-131 therapy - a technical point of view from a single centre's own experience.
Chalewska W; Cegla P; Moczulska A; Strzemecka E; Sackiewicz A; Dedecjus M
Nucl Med Rev Cent East Eur; 2024; 27(0):1-5. PubMed ID: 38529769
[TBL] [Abstract] [Full Text] [Related]
2. The value of the first postoperative diagnostic I-131 scan in patients with papillary thyroid carcinoma.
Ran B; Shang J; Chen Y; Zhou M; Li H; He W; Li Y; Cai Q; Guo B; Gong J; Xu H
J Cancer Res Clin Oncol; 2024 Feb; 150(2):80. PubMed ID: 38319395
[TBL] [Abstract] [Full Text] [Related]
3. A predictive model for patients with local-regionally advanced oropharyngeal squamous cell carcinoma treated after cervical lymph node dissection.
Xie X; Kang M; Qu Z; Gu K
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17241-17251. PubMed ID: 37804427
[TBL] [Abstract] [Full Text] [Related]
4. Oncological outcomes and prognostic factors of squamous cell carcinoma of the upper gingiva and hard palate: a retrospective study.
Cheval M; Lopez R; Delanoë F; Vergez S; Dupret-Bories A; Lusque A; Chabrillac E
Eur Arch Otorhinolaryngol; 2023 Oct; 280(10):4569-4576. PubMed ID: 37233750
[TBL] [Abstract] [Full Text] [Related]
5. Impact of microscopic extrathyroidal extension on differentiated thyroid cancer post-surgical risk of recurrence: a retrospective analysis.
Patti L; Gay S; Musso L; Maltese C; Spina B; Minuto M; Morbelli S; Vera L; Boschetti M; Ferone D; Albertelli M
J Endocrinol Invest; 2023 Oct; 46(10):2157-2164. PubMed ID: 36976482
[TBL] [Abstract] [Full Text] [Related]
6. The optimal number of examined lymph nodes for accurate nodal staging and favorable prognosis of oral tongue squamous cell carcinoma.
Zhuge L; Cai H; Huang Z; Wang S; Li Z
Oral Oncol; 2023 May; 140():106368. PubMed ID: 36966671
[TBL] [Abstract] [Full Text] [Related]
7. Clinical T2N0M0 Esophageal cancer-Is Treatment Pathway Associated With Overall Survival?
Ma W; Nuckles B; Frank K; Young KA; Hoffman RL; Blansfield JA
J Surg Res; 2023 Mar; 283():205-216. PubMed ID: 36410237
[TBL] [Abstract] [Full Text] [Related]
8. Breast cancer Subtypes in Northern Thailand and Barriers to satisfactory survival outcomes.
Ditsatham C; Sripan P; Chaiwun B; Klunklin P; Tharavichitkul E; Chakrabandhu S; Muangwong P; Chitapanarux I
BMC Cancer; 2022 Nov; 22(1):1147. PubMed ID: 36348356
[TBL] [Abstract] [Full Text] [Related]
9. The Survival and Prognosis Characteristics of Primary Esophageal Small-Cell Carcinoma.
Li J; Zhang X; Xu X; Zhao Q; Yang Q; He M; Chen X; Zhao J
Dis Markers; 2022; 2022():5615009. PubMed ID: 36246556
[TBL] [Abstract] [Full Text] [Related]
10. [Risk factors for recurrence and survival analysis in locally advanced T4a papillary thyroid carcinoma after R0 resection].
Chen JM; Fang JG; Zhong YS; Lin LZ; Hou HZ; Ma L; Feng SZ; He Q; Shi M; Lian R; Wang XX; Shen X
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Sep; 57(9):1044-1051. PubMed ID: 36177557
[No Abstract] [Full Text] [Related]
11. A Recurrence Predictive Model for Node-negative Esophageal Squamous Cell Carcinoma After Upfront Esophagectomy.
Hu SY; Gao HJ; Jiang ZH; Shi GD; Wang HF; Ai JS; Wei YC
Semin Thorac Cardiovasc Surg; 2024 Spring; 36(1):102-111. PubMed ID: 36089122
[TBL] [Abstract] [Full Text] [Related]
12. The minimum number of examined lymph nodes for accurate nodal staging and optimal survival of stage T1-2 esophageal squamous cell carcinoma: A retrospective multicenter cohort with SEER database validation.
Tian D; Li HX; Yang YS; Yan HJ; Jiang KY; Zheng YB; Zong ZD; Zhang HL; Guo XG; Wen HY; Chen LQ
Int J Surg; 2022 Aug; 104():106764. PubMed ID: 35803513
[TBL] [Abstract] [Full Text] [Related]
13. Clinical Understaging, Treatment Response, and Survival Among Esophageal Adenocarcinoma Patients.
da Costa WL; Gu X; Farjah F; Groth SS; Burt BM; Ripley RT; Massarweh NN
J Surg Res; 2022 Nov; 279():256-264. PubMed ID: 35797753
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic analysis of lymph node ratio of patients with disease recurrence previously submitted to cervical dissection surgery for head and neck cancer.
Ramos JPZ; Machado FR; Merhi VAL; Aquino JLB
Rev Col Bras Cir; 2022; 49():e20223178. PubMed ID: 35674632
[TBL] [Abstract] [Full Text] [Related]
15. Histopathological Characteristics of N1b Papillary Thyroid Carcinoma are Associated with Risk of Recurrence.
Carmel Neiderman NN; Duek I; Kuzmenko B; Ringel B; Warshavsky A; Muhanna N; Horowitz G; Fliss DM
World J Surg; 2022 Aug; 46(8):1917-1925. PubMed ID: 35543736
[TBL] [Abstract] [Full Text] [Related]
16. Sociodemographic and Facility-Related Disparities in the Delivery of Guideline-Concordant Therapy Among Patients With Esophageal Adenocarcinoma.
da Costa WL; Camp ER; Thrift AP
JCO Oncol Pract; 2022 Jul; 18(7):e1181-e1197. PubMed ID: 35436147
[TBL] [Abstract] [Full Text] [Related]
17. Evaluation of Diagnostic Value of SPECT/CT Imaging in Post-radioiodine Therapy in Thyroid cancer.
Al Hatmi A; Jain A; Mittal AK; Hussain S
Sultan Qaboos Univ Med J; 2022 Feb; 22(1):74-81. PubMed ID: 35299812
[TBL] [Abstract] [Full Text] [Related]
18. Incorporation of adverse features in advanced oral cancer improves precision in staging and patient prognostication.
Singh M; Thankappan K; Balasubramanian D; Pillai V; Shetty V; Rangappa V; Chandrasekhar NH; Kekatpure V; Kuriakose MA; Krishnamurthy A; Mitra A; Pattatheyil A; Jain P; Iyer S; Iyer NG; Subramaniam N;
Head Neck; 2022 Apr; 44(4):964-974. PubMed ID: 35102642
[TBL] [Abstract] [Full Text] [Related]
19. The ideal approach for treatment of cT1N+ and cT2Nany esophageal cancer.: a NCDB analysis.
Huang B; Chan EG; Pennathur A; Luketich JD; Zhang J
BMC Cancer; 2021 Dec; 21(1):1334. PubMed ID: 34911468
[TBL] [Abstract] [Full Text] [Related]
20. Risk prediction of occult lymph node metastasis in patients with clinical T1 through T2 N0 esophageal squamous cell carcinoma.
Yun JK; Kim HR; Park SI; Kim YH
J Thorac Cardiovasc Surg; 2022 Jul; 164(1):265-275.e5. PubMed ID: 34801263
[TBL] [Abstract] [Full Text] [Related]
[Next]
